HbA1c Above 8? Here's Exactly What Your Doctor Should Do — and What You Should Demand

What HbA1c of 8% Actually Means

When your HbA1c report comes back at 8.0%, most patients stare at the number and feel a vague sense of alarm — but don't fully understand what it's telling them. Let me explain it precisely, because the math is sobering.

HbA1c measures the percentage of haemoglobin in your red blood cells that has been glycated — coated with glucose — over the past 2–3 months. An HbA1c of 8.0% corresponds to an estimated average blood glucose of approximately 183 mg/dL. For context, a healthy non-diabetic person has an average blood glucose around 90–100 mg/dL — roughly half that level. At 8%, your blood is running at nearly double the sugar concentration that your body's organs, nerves, and blood vessels were designed for.

The relationship between HbA1c and average glucose follows a predictable formula. An HbA1c of 7% = ~154 mg/dL average. Each 1% rise in HbA1c adds approximately 29 mg/dL to your average glucose. So HbA1c 9% = ~212 mg/dL average. HbA1c 10% = ~240 mg/dL. These numbers matter because at each step, the rate of organ damage accelerates non-linearly — the harm is not just additive, it compounds.

What's happening inside your body when HbA1c is sustained above 8%? Excess glucose binds to proteins throughout the body in a process called glycation. This damages the endothelium (the lining of blood vessels), triggers inflammation, generates oxidative stress, and impairs the function of virtually every organ system. Small blood vessels — which supply the kidneys, eyes, and nerves — are the most vulnerable. Nerve fibres begin accumulating damage above HbA1c 7%. By 8%, the process is well underway.

The Damage That's Happening Right Now

One of the most important — and most uncomfortable — conversations I have with patients is this: the damage from uncontrolled diabetes is largely silent and cumulative. By the time you feel the symptoms of neuropathy, nephropathy, or retinopathy, meaningful harm has already been done. Action must be taken at the HbA1c level, not at the symptom level.

Neuropathy (Nerve Damage)

Diabetic peripheral neuropathy is the most common complication, affecting up to 50% of people with long-term poorly controlled diabetes. Symptoms — numbness, tingling, burning in the feet and hands — typically appear years after the nerve damage has begun. The threshold for accelerated nerve damage is HbA1c above 7%. At 8%, you are not at the threshold — you are well past it. Every 3-month period of sustained HbA1c above 8 adds to the cumulative nerve injury.

Nephropathy (Kidney Damage)

The kidneys filter 180 litres of blood per day through delicate microscopic filters called glomeruli. Sustained high blood sugar damages these filters, causing protein to leak into the urine (microalbuminuria, then macroalbuminuria) and progressively reducing kidney function measured by eGFR. Diabetic nephropathy is the leading cause of kidney failure requiring dialysis in India. At HbA1c 8%, kidney damage is already being laid down. Catching and reversing this early — before eGFR drops below 60 — is critical.

Retinopathy (Eye Damage)

The retina is exquisitely sensitive to glucose. Diabetic retinopathy is the leading cause of preventable blindness in working-age adults globally. It begins silently — as changes to the microvasculature of the retina that only an ophthalmologist can detect — and progresses to haemorrhage and vision loss if left uncontrolled. At HbA1c 8%, the risk of retinopathy is approximately double that at HbA1c 7%. Annual retinal screening is not optional at this level — it's urgent.

Cardiovascular Disease

People with Type 2 diabetes already carry a 2–4× higher risk of heart disease and stroke compared to non-diabetic individuals. That risk amplifies as HbA1c rises. The 3× higher heart attack risk at HbA1c 8 vs 7 is not theoretical — it is documented in large outcomes trials including the UKPDS and ACCORD studies. If you have other cardiovascular risk factors (hypertension, high cholesterol, family history, smoking), HbA1c 8+ puts you in the highest priority tier for urgent intervention.

The 4 Tests You Need Immediately

If your HbA1c is above 8, there are four tests that should be ordered at your very next appointment — if your doctor hasn't ordered them, ask for them by name. These tests assess what damage has already occurred and what your kidneys are doing right now.

Test 1: eGFR (Estimated Glomerular Filtration Rate)

This blood test tells you how well your kidneys are filtering. A normal eGFR is above 90. eGFR 60–89 indicates mild kidney damage. Below 60 is concerning and requires nephrology input. If your eGFR is declining — even within the normal range — it's a red flag that your blood sugar control is damaging your kidneys. Check eGFR every 3–6 months at HbA1c above 8.

Test 2: Urine ACR (Albumin-to-Creatinine Ratio)

This urine test detects microalbuminuria — early kidney damage before eGFR drops. A normal ACR is under 30 mg/g. Values between 30–300 indicate microalbuminuria; above 300 is macroalbuminuria. This test can catch kidney damage years before it becomes visible on eGFR. If your ACR is elevated, ACE inhibitors or ARBs should be started immediately regardless of blood pressure — this is the standard of care.

Test 3: HbA1c Repeat (Confirm and Baseline)

If this is your first HbA1c above 8, confirm the result and establish a baseline. If you're already on treatment, a repeat in 3 months (after protocol changes) is your first milestone — targeting at least a 1.0–1.5 point reduction.

Test 4: Fasting Lipid Panel + Optician Referral

HbA1c above 8 dramatically increases cardiovascular risk — so a full lipid panel (LDL, HDL, triglycerides) is essential to assess your total risk profile. Simultaneously, arrange a dilated retinal examination with an ophthalmologist. You should have a retinal check at a minimum of once per year — and urgently at first diagnosis of HbA1c above 8.

The 90-Day Plan to Get Below 7

HbA1c reflects your average blood glucose over the past 3 months. This means that with the right intervention started today, you can see a meaningful improvement in your very next HbA1c test — typically taken 12 weeks later. Here is the structured 90-day protocol we use at Gini Hospital for patients presenting with HbA1c above 8.

Week 1–2: Medication Audit and CGM Setup

The first step is a complete medication review. What are you currently taking? At what doses? For how long? Have the doses been escalated as needed? Many patients coming to us with HbA1c above 8 are on subtherapeutic doses of metformin alone — and have never had their regimen reviewed since diagnosis. A medication audit frequently reveals that the right drugs are not being used at the right doses.

We also recommend continuous glucose monitoring (CGM) for the first 2–4 weeks. Seeing your glucose in real time — understanding exactly which meals spike you, how your morning fasting glucose behaves, how exercise affects your levels — is transformative. Patients who use CGM engage far more effectively with dietary changes than those relying on once-daily finger-prick readings.

Week 1–4: Diet Overhaul

For North Indian patients specifically, the dietary changes that make the biggest difference are straightforward but require commitment:

• Eliminate white rice entirely or replace with brown rice or millets (bajra, jowar, ragi) — this single change can drop average glucose by 20–30 mg/dL
• Replace maida-based rotis, naan, and paratha with whole wheat or millet rotis
• Eliminate all sugary drinks, fruit juices, packaged snacks, and mithai — these are glycaemic spikes with no nutritional value
• Stop chai with 2+ sugars; replace with black chai or green tea
• Increase vegetable intake dramatically — leafy greens, cruciferous vegetables, and legumes at every meal
• Eat in a 10–12 hour feeding window (e.g., 8am–8pm) to allow overnight metabolic recovery

Week 1–4: Exercise Protocol

Exercise is the most underused glucose-lowering intervention in diabetes. It works through two mechanisms: acute glucose uptake by muscles during exercise (reducing post-meal spikes), and long-term improvement in insulin sensitivity. The minimum target is 150 minutes per week of moderate-intensity aerobic exercise, with resistance training 2× per week. Post-meal walks of 15–20 minutes are particularly effective — even a 10-minute walk after dinner can reduce the post-meal glucose spike by 30–40 mg/dL.

Weekly Targets (Tracking Progress)

• Week 2: Fasting glucose below 140 mg/dL consistently
• Week 4: Post-meal 2-hour glucose below 180 mg/dL
• Week 8: Fasting glucose below 120 mg/dL; post-meal below 160 mg/dL
• Week 12: HbA1c repeat — targeting 6.5–7.5 depending on starting point

When to Ask for a Medication Upgrade

If your HbA1c has been above 8 for more than 3 months on your current medication regimen, your regimen needs to change. This is not a failure — it is the natural history of Type 2 diabetes, which is a progressive condition. The evidence-based response is to escalate treatment, not to keep doing the same thing and expect different results.

Signs Your Current Regimen Isn't Working

• HbA1c above 8 on two consecutive tests (6 months) despite good adherence
• Fasting glucose consistently above 150 mg/dL on current medication
• Post-meal glucose routinely above 220 mg/dL
• You haven't had a medication review in more than 12 months
• You're on metformin alone at a standard dose — and nothing has changed in years

GLP-1 Candidacy

GLP-1 receptor agonists (semaglutide/Ozempic, tirzepatide/Mounjaro) have transformed diabetes management. They lower HbA1c by an average of 1.5–2.5 points, cause significant weight loss (6–22% of body weight depending on the agent), and have proven cardiovascular and renal protective benefits. If your HbA1c is above 8 and your BMI is above 27, or you have cardiovascular risk factors, you are likely a GLP-1 candidate. Ask your doctor by name: "Am I a candidate for a GLP-1 receptor agonist?"

When to Add Insulin vs Intensify Oral Medication

Adding basal insulin (long-acting insulin) is appropriate when HbA1c remains above 9–10% despite maximally optimised oral therapy, when fasting glucose is consistently above 180 mg/dL, or when there are signs of significant beta-cell exhaustion (low C-peptide). However, before jumping to insulin in patients with HbA1c 8–9, there is almost always an opportunity to try GLP-1 therapy, SGLT-2 inhibitors (which also protect the kidneys and heart), and DPP-4 inhibitors in combination. Insulin should be a considered decision — not a default.

Questions to Ask Your Doctor at Your Next Appointment

Most patients leave their diabetes appointments without asking the questions that matter most. Here are the power questions you should ask — and what to expect as answers from a well-informed clinician:

1. "What is my eGFR trend over the past year?" — Not just the current value, but whether it is stable, declining, or improving. A downward trend is an urgent signal even if the current value is still "normal."
2. "Has my medication been optimised for my current HbA1c?" — If your HbA1c is above 8 and your medication hasn't changed in 12 months, ask why.
3. "Am I a candidate for a GLP-1 receptor agonist?" — Know the answer to this before you leave the room.
4. "When did I last have a retinal examination?" — Annual retinal screening is non-negotiable at HbA1c above 8. If you don't have a referral, ask for one.
5. "What is my 90-day HbA1c target and how will we measure progress?" — Get a specific, measurable target. "We'll see how you do" is not an acceptable answer when your HbA1c is above 8.
6. "Do I need a C-peptide test?" — This measures your residual insulin-producing capacity and helps determine whether you are a good candidate for lifestyle reversal vs need for permanent medication escalation.